Time Course of the Protective Effect of Inhaled Heparin on Exercise-induced Asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 5, 1996, Pages 1702-1707

  Garrigo, Jose ^a   Danta, Ignacio ^a   Ahmed, Tahir ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROMOGLYCATE DISODIUM; HEPARIN;

ADULT; AIRWAY CONDUCTANCE; ARTICLE; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; EXERCISE INDUCED ASTHMA; FEMALE; HEART RATE; HEART WORK; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; LUNG MINUTE VOLUME; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREADMILL EXERCISE;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AIRWAY RESISTANCE; ANTI-ASTHMATIC AGENTS; ASTHMA, EXERCISE-INDUCED; BRONCHI; CROMOLYN SODIUM; EXERCISE TEST; FEMALE; HEART RATE; HEPARIN; HUMANS; LUNG; MALE; MAST CELLS; NEBULIZERS AND VAPORIZERS; PLACEBOS; REPRODUCIBILITY OF RESULTS; RESPIRATION; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 0029925092     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.5.8630624     Document Type: Article

References (21)

1. Hirsh, J. 1991. Heparin. N. Engl. J. Med. 324:1565-1574.
2. Jaques, L. B. 1979. Heparins: anionic polyelectrolyte drugs. Pharmacol. Rev. 31:99-166.
3. Ofosu, F. A., I. Danishafsky, and J. Hirsch, editors. 1989. Heparin and related polysaccharides: structure and activities. Ann. N. Y. Acad. Sci. 556:1-501.
4. Lane, D. A., and L. Adams. 1993. Non-anticoagulant uses of heparin (editorial). N. Engl. J. Med. 329:129-130.
5. Dolowitz, D. A., and T. F. Dougherty. 1960. The use of heparin as an anti-inflammatory agent. Laryngoscope 70:873-884.
6. Seeds, E. A., J. Hanss, and C. P. Page. 1993. The effect of heparin and related proteoglycans on allergen and PAF-induced eosinophil infiltration. J. Lipid Mediat. 7:269-278.
7. Nelson, R. M., O. Cecconi, W. G. Roberts, A. Aruffo, R. J. Linhardt, and M. P. Bevilacqua. 1993. Heparin oligosaccharides bind L- and P-Selectin and inhibit acute inflammation. Blood 82:3253-3258.
8. Lucio, J., J. D'Brot, C. B. Guo, W. M. Abraham, L. M. Lichtenstin, A. Kagey-Sobotka, and T. Ahmed. 1992. Immunologic mast cell mediated responses and histamine release are attenuated by heparin. J. Appl. Physiol. 73:1093-1101.
9. 3-mediated mast cell degradation. J. Appl. Physiol. 76:893-901.
10. Ahmed, T., W. M. Abraham, and J. D'Brot. 1992. Effect of inhaled heparin on immunologic and non-immunologic bronchoconstrictor responses in sheep. Am. Rev. Respir. Dis. 145:566-570.
11. Bowler, S. D., S. M. Smith, and P. S. Lavercombe. 1993. Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects. Am. Rev. Respir. Dis. 147:160-163.
12. Ahmed, T., J. Garrigo, and I. Danta. 1993. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N. Engl. J. Med. 329:90-95.
13. Ahmed, T., T. Syriste, J. Lucio, M. Robinson, W. M. Abraham, and J. D'Brot. 1993. Inhibition of antigen-induced airway and cutaneous responses by heparin: a pharmacodynamic study. J. Appl. Physiol. 74:1492-1498.
14. König, P., N. L. Hordvik, and C. Kreut. 1987. The preventive effect and duration of action of nedocromil sodium and cromolyn sodium on exercise-induced asthma (EIA) in adults. J. Allergy Clin. Immunol. 79:64-68.
15. Patel, K. R., K. E. Berkin, and J. W. Kerr. 1982. Dose-response study of sodium cromoglycate in exercise-induced asthma. Thorax 37:663-666.
16. Wilson, O., A. L. Jacobs, J. Stewart, and D. D. Carson. 1990. Expression of externally disposed heparin/heparan sulfate binding sites by uterine epithelial cells. J. Cellular Physiol. 143:60-67.
17. O'Byrne, P. M., N. C. Thomson, M. Morris, R. S. Roberts, E. E. Daniel, and F. E. Hargreave. 1983. The protective effect of inhaled chlorpheniramine and atropine on bronchoconstriction stimulated by airway cooling. Am. Rev. Respir. Dis. 128:611-617.
18. 4-receptor antagonist. N. Engl. J. Med. 323:1736-1739.
19. Israel, E., R. Dermarkarian, M. Rosenberg, R. Sperling, G. Taylor, P. Rubin, and J. M. Drazen. 1990. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N. Engl. J. Med. 323: 1740-1744.
20. Fine, N. L., C. Shim, and M. H. Williams, Jr. 1968. Objective evaluation of heparin in the treatment of asthma. Am. Rev. Respir. Dis. 98: 886-887.
21. Ghosh, T. K., P. S. Eis, J. M. Mullaney, C. L. Ebert, and D. L. Gill. 1988. Competitive, reversible and potent antagonism of inositol 1,4,5-triphosphate-activated calcium release by heparin. J. Biol. Chem. 263:11075-11079.